Search Results - "Hennebelle, Isabelle"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Hospicells (ascites‐derived stromal cells) promote tumorigenicity and angiogenesis by Pasquet, Marlene, Golzio, Muriel, Mery, Eliane, Rafii, Arash, Benabbou, Nadia, Mirshahi, Pezhman, Hennebelle, Isabelle, Bourin, Philippe, Allal, Ben, Teissie, Justin, Mirshahi, Massoud, Couderc, Bettina

    Published in International journal of cancer (01-05-2010)
    “…The microenvironment is known to play a dominant role in cancer progression. Cells closely associated with tumoral cells, named hospicells, have been recently…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Contribution of apoptosis in the cytotoxicity of the oxaliplatin–irinotecan combination in the HT29 human colon adenocarcinoma cell line by Arnould, Stéphanie, Guichard, Sylvie, Hennebelle, Isabelle, Cassar, Georges, Bugat, Roland, Canal, Pierre

    Published in Biochemical pharmacology (15-10-2002)
    “…Interactions between the topoisomerase I inhibitor irinotecan (CPT-11) and the platinum derivative oxaliplatin (L-OHP) were investigated in HT29 colon cancer…”
    Get full text
    Journal Article
  5. 5

    Assessment of efficacy of postinfusion tubing flushing in reducing risk of cytotoxic contamination by Claraz, Pauline, Riff, Isabelle, Vert, Charlotte, Wolff, Elina, Perriat, Sophie, Grand, Anaïs, Cretu, Yann, Hennebelle, Isabelle, Canonge, Jean-Marie, Puisset, Florent

    Published in American journal of health-system pharmacy (30-10-2020)
    “…Abstract Purpose Infusion of cytotoxic drugs carries the risk of occupational exposure of healthcare workers. Since disconnecting an infusion line is a source…”
    Get full text
    Journal Article
  6. 6

    A Chemiluminescent Microplate Assay to Detect DNA Damage Induced by Genotoxic Treatments by Salles, Bernard, Provot, Christian, Calsou, Patrick, Hennebelle, Isabelle, Gosset, Isabelle, Fournié, Gilbert J.

    Published in Analytical biochemistry (20-11-1995)
    “…A damaged DNA detection assay (3D assay) using plasmid DNA adsorbed on sensitized microplates as the substrate for anin vitrorepair reaction is presented. DNA…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Unexpected high levels of vorinostat when combined with vinorelbine in patients with advanced cancer by Gandia, Peggy, Arellano, Cecile, Chalret du Rieu, Quentin, Lochon, Isabelle, Campone, Mario, Pierga, Jean-Yves, Poublanc, Muriel, Hennebelle, Isabelle, Filleron, Thomas, Chatelut, Etienne, Delord, Jean-Pierre

    Published in Current clinical pharmacology (01-11-2011)
    “…This study was a multi-centre, dose-escalation trial in patients with advanced cancers. Primary objective was to determine maximum tolerated dose (MTD) of…”
    Get more information
    Journal Article
  9. 9
  10. 10

    Gene expression profiling on pre- and post-erlotinib tumors from patients with head and neck squamous cell carcinoma by Thomas, Fabienne, Delmar, Paul, Vergez, Sébastien, Rochaix, Philippe, Hennebelle, Isabelle, McLoughlin, Patricia, Benlyazid, Adil, Sarini, Jérôme, Delord, Jean-Pierre

    Published in Head & neck (01-06-2013)
    “…Background The purpose of our work was to identify genomic predictive markers of erlotinib response in patients with head and neck squamous cell carcinoma…”
    Get full text
    Journal Article
  11. 11

    Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophages by Castells, Magali, Thibault, Benoît, Mery, Eliane, Golzio, Muriel, Pasquet, Marlene, Hennebelle, Isabelle, Bourin, Philippe, Mirshahi, Massoud, Delord, Jean Pierre, Querleu, Denis, Couderc, Bettina

    Published in Cancer letters (29-12-2012)
    “…Abstract Within the microenvironment, Carcinoma-associated mesenchymal stem cells (Hospicells) are able to influence ovarian tumor development via, among…”
    Get full text
    Journal Article
  12. 12

    Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report by Laurenty, Anne-Pascale, Thomas, Fabienne, Chatelut, Etienne, Bétrian, Sarah, Le Guellec, Chantal, Hennebelle, Isabelle, Le Guellec, Sophie, Chevreau, Christine

    Published in Pharmacogenomics (01-09-2013)
    “…We describe here the case of a 60-year old male patient treated for an extensive local progression of a pleiomorphic sarcoma on the right tibial crest with…”
    Get more information
    Journal Article
  13. 13

    Dexamethasone as a probe for docetaxel clearance by PUISSET, Florent, CHATELUT, Etienne, ROCHE, Henri, DALENC, Florence, BUSI, Florent, CRESTEIL, Thierry, AZEMA, Joëlle, POUBLANC, Muriel, HENNEBELLE, Isabelle, LAFONT, Thierry, CHEVREAU, Christine

    Published in Cancer chemotherapy and pharmacology (01-09-2004)
    “…A pilot study was conducted in 23 patients in order to assess the correlation between docetaxel clearance (CL) and pharmacokinetics of dexamethasone…”
    Get full text
    Journal Article
  14. 14

    Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line by Guichard, Sylvie, Hennebelle, Isabelle, Bugat, Roland, Canal, Pierre

    Published in Biochemical pharmacology (01-03-1998)
    “…CPT-11 (irinotecan) is a DNA topoisomerase I inhibitor active against metastatic colorectal carcinoma. We investigated, in a human colon carcinoma cell line,…”
    Get full text
    Journal Article
  15. 15

    Sequence‐dependent activity of the irinotecan‐5FU combination in human colon‐cancer model HT‐29 in vitro and in vivo by Guichard, Sylvie, Cussac, Daniel, Hennebelle, Isabelle, Bugat, Roland, Canal, Pierre

    Published in International journal of cancer (27-11-1997)
    “…Irinotecan, a DNA‐topoisomerase‐I inhibitor, is active against metastatic colon carcinoma. We investigated the effects of irinotecan and 5FU combinations in…”
    Get full text
    Journal Article
  16. 16

    Schedule-dependent activity of topotecan in OVCAR-3 ovarian carcinoma xenograft : Pharmacokinetic and pharmacodynamic evaluation by GUICHARD, Sylvie, MONTAZERI, Ashraf, CHATELUT, Etienne, HENNEBELLE, Isabelle, BUGAT, Roland, CANAL, Pierre

    Published in Clinical cancer research (01-10-2001)
    “…Topotecan is a topoisomerase (Topo) I inhibitor used in ovarian carcinoma chemotherapy. Topo I inhibitors are thought to be more cytotoxic using protracted…”
    Get full text
    Journal Article
  17. 17

    Combination of oxaliplatin and irinotecan on human colon cancer cell lines: activity in vitro and in vivo by Guichard, Sylvie, Arnould, Stéphanie, Hennebelle, Isabelle, Bugat, Roland, Canal, Pierre

    Published in Anti-cancer drugs (01-10-2001)
    “…The in vitro and in vivo combination of oxaliplatin and irinotecan was investigated in a panel of four human colon cancer cell lines and their counterpart…”
    Get full text
    Journal Article
  18. 18

    Schedule-dependent Activity of Topotecan in OVCAR-3 Ovarian Carcinoma Xenograft by Sylvie Guichard, Ashraf Montazeri, Etienne Chatelut, Isabelle Hennebelle, Roland Bugat, Pierre Canal

    Published in Clinical cancer research (01-10-2001)
    “…Topotecan is a topoisomerase (Topo) I inhibitor used in ovarian carcinoma chemotherapy. Topo I inhibitors are thought to be more cytotoxic using protracted…”
    Get full text
    Journal Article
  19. 19

    Characterization of CPT-11 converting carboxylesterase activity in colon tumor and normal tissues: comparison with p-nitro-phenylacetate converting carboxylesterase activity by Hennebelle, Isabelle, Terret, Catherine, Chatelut, Etienne, Bugat, Roland, Canal, Pierre, Guichard, Sylvie

    Published in Anti-cancer drugs (01-07-2000)
    “…Irinotecan (CPT-11) is a topoisomerase I inhibitor commonly used in the treatment of colorectal tumors. It is a prodrug, converted to an active metabolite,…”
    Get full text
    Journal Article
  20. 20